Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 24, 1992 - Issue sup84
Submit an article Journal homepage
87
Views
6
CrossRef citations to date
0
Altmetric
Miscellany

Congenital Toxoplasmosis

Morten Lebech
&
Eskild Petersen
Pages 1-96 | Published online: 02 Jan 2015

References

  • World Health Organization. Technical Report Services No. 497. Genetic disorders: preventions, treatment and rehabilitation. Geneva. 1972
  • Knoppers BM, Laberge CM, eds. Genetic Screening. Excerpta Medica, 1990
  • Hummer L, Munkner T, Sølvsten Sørensen S, Brandt NJ, Brock Jacobsen B. Screening for kongenit hypothyreose i Danmark. Ugeskr Laeg 144: 1001–1004, 1982
  • Arends J, Nørgaard-Pedersen B. Immunofluorometry of thyrotropin from whole-blood spots on filter paper, to screen for congenital hypothyroidism. Clin Chem 32: 1854–1856, 1986
  • Xu Yong-Yuan, Petterson K, Blomberg K, Hemmilä I, Mikola H, Lövgren T. Simultaneous Quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17α-hydroxyprogesterone, immunoreactive trypsin and creatine kinase MM in dried blood spot. Clin. Chem 1992, (in press).
  • Zhang Yao-Hua, McCabe ERB. What's new in DNA/RNA? In: Wilcken B, Webster D, eds. Neonatal Screening in the Nineties. The Kelvin Press, 2 Paton Place, Manly Vale, New South Wales, 2093 Australia, 219, 1991
  • Gregersen N, Nørgaard-Pedersen B, Winter V, Knudsen I, Sneidermann T, Kølvraa S, Bolund L, Blakemore A, Curtis D. Determination of the frequency of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in England and Denmark by a PCR/Restriction enzyme cleavage method. In: Wilcken B, Webster D, eds. Neonatal Screening in the Nineties. The Kelvin Press, 2 Paton Place, Manly Vale, New South Wales, 2093 Australia, 232, 1991
  • Dahlén P. Time-resolved fluorometry in nucleic acid hybridization assays. Academic Dissertation. University of Turku, Finland, 1991
  • Iitiä A, Høgdali E, Dahlen P, Siitari H. Detection of the cystic fibrosis deletion F508 using time-resolved fluorometry. In: Wilcken B, Webster D, eds. Neonatal Screening in the Nineties. The Kelvin Press, 2 Paton Place, Manly Vale, New South Wales, 2093 Australia, 173, 1991

References

  • Frenkel JK. Congenital toxoplasmosis: Prevention or palliation? Am J Obstet Gynecol 141: 359–361, 1981
  • Klapper PE, Morris DJ. Screening for viral and protozoal infections in pregnancy. A review. Br J Obstet Gynaecol 97: 974–983, 1990
  • Ho-Yen DO, Chatterton JMW. Congenital toxoplasmosis - why and how to screen. Reviews in medical microbiology 1: 229–235, 1990
  • Desmonts G, Couvreur J. Toxoplasmosis: Epidemiologic and serologic aspects of perinatal infection. Prog Clin Biol Res 3: 115–132, 1975
  • Foulon W, Naessens A, Volckaert M, Lauwers S, Amy JJ. Congenital toxoplasmosis: A prospective survey in Brussels. Br J Obstet Gynaecol 91: 419–423, 1984
  • Frenkel JK. Breaking the transmission chain of toxoplasma: A program for the prevention of human toxoplasmosis. Bull N Y Acad Med 50: 228–235, 1974
  • Wilson CB, Remington JS. What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 138: 357–363, 1980
  • Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 72: 363–366, 1988
  • Fuchs F, Kimball AC, Kean BH. The management of toxoplasmosis in pregnancy. Clin Perinatol: 407–422, 1974
  • Henderson J, Beattie CP, Hale EG, Wright T. The evaluation of new services: Possibilities for preventing congenital toxoplasmosis. Int J Epidemiol 13: 65–72, 1984
  • Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. In: Thalhammer O, Baumgarten K, Pollack A, eds. Pathophysiology of congenital disease. Stuttgart: George Thieme: 51–60, 1979
  • Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318: 271–275, 1988
  • Cazenave J, Forestier F, Bessières MH, Broussin B, Begueret J. Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 12: 119–127, 1992
  • Foulon W, Naessens A, Mahler T, De Waele M, De Catte L, De Meuter F. Prenatal diagnosis of congenital toxoplasmosis. Obstet Gynecol 76: 769–772, 1990

References

  • Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders, 89–195, 1990
  • Desmonts G, Couvreur J. Toxoplasmosis. In: Conn RB, eds. Current Diagnosis 7. Philadelphia: WB Saunders, 274–287, 1985
  • Decoster A, Darcy F, Caron A, Vinatier D, Houze de L'Aulnois D, Vittu G, Niel G, Heyer F, Lecolier B, Delcroix M, Monnier JC, Duhamel M, Capron A. Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection. Clin Exp Immunol 87: 310–315, 1992
  • Pujol M, Morel C, Malbruny B. Intérêt de la recherche des IgA dans le diagnostic de la toxoplasmose. Path Biol 37: 893–896, 1989
  • Pinon JM, Toubas D, Marx C, Mougeot G, Bonnin A, Bonhomme A, Villaume M, Foudrinier F, Lepan H. Detection of specific immunoglobin E in patients with toxoplasmosis. J Clin Microbiol 28: 1739–1743, 1990
  • Hedman K, Lappalainan M, Seppaia E, Makela O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159: 736–740, 1989
  • Suzuki Y, Thulliez P, Desmonts G, Remington JS. Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of toxoplasma infection in humans. J Clin Microbiol 26: 901–905, 1988
  • Dannemann BR, Vaughan WC, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 28: 1928–1933 1990
  • Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet: 500–504, 1985
  • Hohlfeld P, Mac Aleese J, Capella-Pavlovski M, Giovangrandi Y, Thulliez P, Forestier F, Daffos F. Fetal toxoplasmosis: Ultrasonographic signs. Ultrasound Obstet Gynecol 1: 241–244, 1991
  • Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318: 271–275, 1988
  • Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 28: 2297–2301, 1990
  • Dupouy-Camet J, Lavareda De Souza S, Bougnoux ME, Mandelbrot L, Hennequin C, Dommergues M, Benarous R, Tourte Schaeffer C. Letter. Lancet 1018, 1990
  • Cazenave J, Forestier F, Bessieres MH, Broussin B, Begueret J. Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diag 12: 119–127, 1992
  • Forestier F, Cox WL, Daffos F, Rainaut M. The assessment of fetal blood samples. Am J Obstet Gynecol 158: 1184–1188, 1988
  • Thulliez P. Toxoplasmose congénitale: Résultats de 105 diagnostics prénatals positifs. Bull Soc Fr Parasitol (VIIth ICOPA, Paris) 8: 1001, 1990
  • Derouin F, Thulliez P, Candolfi E, Daffos F, Forestier F. Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol 7: 423–425, 1988
  • Hohlfeld P, Daffos F, Thulliez P, Aufrant J, Couvreur J, Mac Aleese D, Descombey D, Forestier F. Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in-utero treatment. J Pediatr 115: 765–769, 1989

References

  • Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and the Newborn Infant. 3rd. ed. Philadelphia: WB Saunders 90–195, 1990
  • Desmonts G, Couvreur J. Toxoplasmose congenitale. Etude prospective de l'issue de la grossesse chez 542 femmes atteintes de toxoplasmose acquise en cours de gestation. Ann Pediat 31: 805–9, 1984
  • Couvreur J, Desmonts C. Behandlung der erworben Toxoplasmose wahrend der schwangerschaft mit spiramycin. Zbl Gynakol 105: 1104–1107, 1983
  • Eichenwald HF. A study of congenital toxoplasmosis. In: Human toxoplasmosis. Copenhagen Denmark, Williams & Wilkins Co. 41–19, 1959
  • Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical Toxoplasma infection. Pediatrics 66: 767–774, 1980
  • Koppe JG, Loewer-Sieger DM, Roever-Bonnet H. Results of 20-years follow up of congenital toxoplasmosis. Lancet, Feb 1, 254–56, 1986
  • Stray-Pedersen B, Lorentzen-Styr AM. Epidemiological aspects of Toxoplasma infections among women in Norway. Acta Obstet Gynecol 59: 323–326, 1980
  • McCabe RE, Oster S. Current recommendations and future prospects in treatment of toxoplasmosis. Drugs 38: ( S6) 973–987, 1989
  • Mitchell CD, Erlich SE, Mastrucci MT. Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1. Pediatr Infect Dis J 9: 512–18, 1990
  • Harpey JP, Darbois Y, Lefebvre G. Teratogenicity of Pyrimethamine. Lancet 2: 399, 1983
  • Anonymous (editorial). Pyrimethamine combinations in pregnancy. Lancet 2: 1005–7, 1983
  • Drugs in pregnancy and lactation. Briggs GG, Freeman RK, Yaffe SJ, eds. Baltimore, Williams & Wilkins, 1990
  • Hengst P. Untersuchungen zur teratogeni von Daraprim (Pyrimethamin) beim menschen. Zbl Gynak 94: 551–555, 1972
  • Piens MA, Garin JP. New perspective in the chemoprophylaxis of toxoplasmosis. J Chemother 1: 46–51, 1989
  • Huskinson-Mark J, Araujo FG, Remington JS. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 164: 170–177, 1991
  • Kraubig H. Preventive Behandlung der konnatalen toxoplasmosis. In: Kirchoff H & Kraubig H (eds): Toxoplasmosis. Praktische fragen und ergebnisse. Stuttgart, George Thiemes Verlag 104–122, 1966
  • Thalhammer O, Heller-Szollosy E. Erfarungen mit routinemassigem toxoplasmose screening bei schwangeren zwecks verhutung angeborener toxoplasmose. Wiener Klin Wochenschrift 91: 20–25, 1979
  • Stunzner D, Mayer HO, Mose JR. Toxoplasmosis: Screening in pregnancy and surveillance of children born to mothers with acute infection. Hyg Med 15: 530–532, 1990
  • Couvreur J, Desmonts G, Thulliez Ph. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrobial Chemother 22: Suppl B, 193–200, 1988
  • Hohlfeld J, Daffos F, Thulliez PI, Aufrant C, Couvreur J, MacAleese J, Descomber D, Forestier F. Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115: 765–9, 1989
  • Maisonneuve H, Faber C, Piens MA, Garin JP. Toxoplasmose congenitale. Tolerance de l'association sulfadoxine-pyrimethamine. Vingt quatre observations. Presse medicale 13: ( S14) 859–862, 1984
  • Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Eng J Med 318, S5, 271–275, 1988
  • WHO Model Prescribing Information- Drugs used in Parasitic Diseases. WHO publication, 53–60, 1990
  • Roberts T, Frenkel JK. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. JAVMA 196: 249–256, 1990
  • Koskiniemi M, Lappalainen M, Hedman K. Toxoplasmosis needs evaluation. AJDC 143: 724–28, 1989
  • McLoad K, Boyer N, Roizen C. Treatment of congenital toxoplasmosis. 17th. Internat Congress of Chemotherapy, Berlin, June 1991. no. 1933.
  • Stray-Pedersen B. A prospective study of acquired toxoplasmosis among 8043 pregnant women in the Oslo area. Am J Obstet Gynecol 136: 399–403, 1980
  • Stray-Pedersen B. Infants potentially at risk for congenital toxoplasmosis. Am J Dis Child 134: 638–642, 1980
  • Couvreur J, Desmonts G, Aron-Rosa D. Le prognostic oculaire de la toxoplasmose congenitale: Role du traitement. Ann Pediat 31: 855–858, 1984

References

  • Thalhammer O. Die angeborene Toxoplasmose. In: Kirchhoff H & Kräubig H, eds. Toxoplasmose. Praktische Fragen und Ergebnisse. Stuttgart: G Thieme, 1966
  • Thalhammer O. Pränatale Erkrankungen des Menschen. Stuttgart: G Thieme, 442 pp, 1967
  • Thalhammer O. Toxoplasmose in der Schwangerschaft. Mitt d Österr Sanitätsverwaltung 81: 124–127, 1980
  • Flamm H, Aspöck H, Picher O & Werner H. Die Toxoplasmose-Untersuchung von Schwangeren und Neugeborenen. Öst Ärzteztg 30 ( S1): 15–17, 1975
  • Thalhammer O. Die Toxoplasmose-Untersuchung von Schwangeren und Neugeborenen. Wien klin Wschr 87: 676–681, 1975
  • Aspöck H. Diagnostik pränataler Infektionen II: Toxoplasmose. Laboratoriumsblätter (Behring) 26: 12–15, 1976
  • Thalhammer O. Introductory remarks. Some problems surrounding prevention of prenatal Toxoplasma infection. In: Thalhammer O, Baumgarten K & Pollak A, eds. Perinatal Medicine. 6th European Congr. Wien: G Thieme, 44–51, 1979
  • Thalhammer O & Heller-Szöllösy E. Erfahrungen mit routinemäßigem Toxoplasma-Screening bei Schwangeren zwecks Verhütung angeborener Toxoplasmose. Eine prospektive Untersuchung. Wien klin Wschr 91: 20–25, 1979
  • Flamm H & Aspöck H. Die Toxoplasmose-Überwachung der Schwangerschaft in Österreich -Ergebnisse und Probleme. Pädiatr Grenzgeb 20: 27–34, 1981
  • Aspöck H, Picher O, Flamm H & Auer H. Aktuelle Probleme der Serodiagnostik im Rahmen der Toxoplasmose-Überwachung während der Schwangerschaft. Mitt Österr Ges Tropenmed 3: 20–25, 1981
  • Aspöck H. Toxoplasmose. Wien: Hoffmann-La Roche, 43 pp, 1982
  • Aspöck H. Überwachung von Toxoplasmose während der Schwangerschaft. Gynäk Rdsch 23: 57–65, 1982
  • Thalhammer O. Toxoplasmose. 38. Österr Ärztekongreß, Kongreßband, Wien: Österr. Ärztekammer, 159–165, 1984
  • Aspöck H & Flamm H. Die Toxoplasmose-Überwachung während der Schwangerschaft. apibioMerieux-Monographien I: 10-26, 1984
  • Aspöck H. Toxoplasmosis. In: WHO, ed. Prenatal and perinatal infections. Report on a WHO meeting, Graz, 24–26 May, 1982. EURO Reports and Studies 93: 43–51, 1985
  • Aspöck, H. Prevention of Congenital Toxoplasmosis by Serological Surveillance during Pregnancy: Current Strategies and Future Perspectives. In: Marget W, Lang W & Gabler-Sandberger E. eds. Proc IXth Int Congr Infectious and Parasitic Diseases. München: MMV Medizin Verlag, vol. III: 69–72, 1986
  • Aspöck H, Flamm H & Picher O. Die Toxoplasmose-Überwachung während der Schwangerschaft −10 Jahre Erfahrungen in Österreich. Mitt Österr Ges Tropenmed Parasitol 8: 105–113, 1986
  • Aspöck, H & Flamm H. 15 Jahre Toxoplasmose-Überwachung der Schwangeren in Österreich. Ein beispielgebender Erfolg bei der Verhütung von Infektionen des Ungeborenen. Österr Apotheker-Ztg 44: 447–448, 1990
  • Hassl A, Auer H, Hermentin K, Picher O & Aspöck H. Experimental studies on circulating antigen of Toxoplasma gondii in intermediate hosts: criteria for detection and structural properties. Zbl Bakt Hyg A 263: 625–634, 1987
  • Hassl A, Picher O & Aspöck H. Untersuchungen über die Bedeutung des Nachweises von zirkulierendem Antigen für die Aufdeckung einer Erstinfektion mit Toxoplasma gondii während der Schwangerschaft. Mitt Österr Ges Tropenmed Parasitol 9: 91–94, 1987
  • Hermentin K, Hassl A, Picher O & Aspöck H. Comparison of different serotests for specific Toxoplasma IgM-antibodies (ISAGA, SPIHA, IFAT) and detection of circulating antigen in two cases of laboratory acquired Toxoplasma infection. Zbl Bakt Hyg A 270: 534–541, 1989
  • Hassl A, Auer H & Aspöck H. The significance of circulating antigen in the diagnosis of Toxoplasma infections. Eur J Pediatr 15: 605, 1991

References

  • Hengst P. Toxoplasma gondii-Infektion und Schwangerschaft - Untersuchungen zu Fragen der Klinik, Diagnostik und Therapie. Teses, Habilitation Humboldt-Universität Berlin 1978
  • Just W.-H.: Dokumentation und Interpretation von serologischen Untersuchungsergebnissen in der Toxoplasmosediagnostik. Angew Parasitol 25: 171–175, 1984
  • Knaus B.-U. Epidemiologische Befunde zur Toxoplasma gondii-Infektion des Menschen im Raum Cottbus. Angew Parasit 32: 159–164, 1991
  • Ockert G. Personal communication. January 1992
  • Röpke F. Personal communication. January 1992
  • Hengst P., Bollmann R. Indications and problems of fetal IgM examination for toxoplasmosis and rubella infection in pregnancy. XIII. World Congress of Gynec. and Obstet. (FIGO) Singapore September 1991
  • Hengst, P. Zur Effektivität einer generellen Testung auf Toxoplasma gondii-Infektion in der Schwangerschaft. Zbl Gynäkol 104: 949–956, 1982
  • Hengst P. Untersuchungen zur Teratogenität des Daraprim (Pyrimethamin) beim Menschen. Zbl Gynäkol 94: 551–555, 1972
  • Toxoplasmosis and Pregnancy. Recommendations of the Advisory Board of the Federal Health Office, Berlin 1991

References

  • Lelong M. Prophylaxie des toxoplasmoses du nouveau-né et de la femme enceinte. Rev Hyg Méd Soc 7: 71, 1959
  • Desmonts G, Couvreur J. Toxoplasmosis in pregnancy and its transmission to the foetus. Bull N Y Acad Med 50: 146–159, 1974
  • Desmonts G, Couvreur J, Alison F, Baudelot J, Gerbeaux J, Lelong M. Etude épidémiologique sur la toxoplasmose: De l'influence de la cuisson des viandes de boucherie sur la fréquence de l'infection humaine. Rev Franc Etudes Clin Biol 10: 952–958, 1965
  • Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders, 89–195, 1990
  • Roux C, Desmonts G, Mulliez N, Gaulier M, Tufferaud G, Marmor D, Herbillon A. Bilan de deux ans de prophylaxie de la toxoplasmose congénitale à la maternité de l'hôpital Saint-Antoine. J Gynecol Obstet Biol Reprod 5: 249–264, 1976
  • Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318: 271–275, 1988
  • Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 72: 363–366, 1988
  • Goulet V, Le Magny F, Iborra M. Enquête sur la connaissance des mesures préventives contre la toxoplasmose auprès de femmes venant d'accoucher. Bull Epidemiol Hebdom 4: 14–15, 1990
  • Bougnoux ME, Hubert B. Toxoplasmose congénitale: Bilan de la prévention primaire en France. Bull Epidemiol Hebdom 4: 13–14, 1990

Literature

  • Stürchler D, Berger R, Just M: Die konnatale Toxoplasmose in der Schweiz. Schweiz Med Wschr 117( S6): 161–7, 1987
  • Berger R, Fernex M, Just M, Rudin C, Stürchler D: Prävention, Erfassung und Therapie der konnatalen Toxoplasmose in der Region Basel (Schweiz). Z ärztl Forbild 85: 1103–5, 1991
  • Frenkel JK: Toxoplasmosis. Ped Clin of North America 32: 917–32, 1985
  • Couvreur J, Desmonts C: Die Behandlung der konnatalen Toxoplasmose. Zbl Gynäkol 105: 1108–12, 1983
  • Couvreur J, Nottin N, Desmonts G: La toxoplasmose congénitale traitée. Ann Ped 27: 647–52, 1980
  • Garin JP, Mojon M, Piens MA, Chevalier-Nuttall I: Surveillance et traitement de la toxoplasmose chez la femme enceinte, le foetus et le nouveau-né. Pédiatrie 44: 705–12, 1989
  • Maisonneuve H, Faber C, Piens MA, Garin JP: Congenital toxoplasmosis. Tolerance to the pyrimethamine-sulfadoxine combination. 24 cases. Presse Med 13 ( S14): 859–62, 1984
  • Jacquier P: Institute of Parasitology, University of Zurich, Switzerland (unpublished data).
  • Rhyner B: Institute Viollier, Basel, Switzerland (unpublished data).

References

  • Desmonts G, Couvreur J. Toxoplasmosis: Epidemiologic and serologic aspects of perinatal infection. Krugman S and Gershoon AA, eds. Infections of the fetus and newborn infant. Progress in clinical and biological research. New York: Alan R Liss, Inc. 1975
  • Papoz L, Simondon F, Saurin W, Sarmini H. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am J Epidemiol 123: 154–61, 1986
  • Veen van der J, Polak MF. Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection. J Hyg Camb 85: 165–74, 1980
  • Frenkel JK. Breaking the transmission chain of toxoplasma: A program for the prevention of human toxoplasmosis. Bull NY Acad Med 50: 228–35, 1974
  • Desmyter J, Goubau P, Donders G, Letters to the editor. Lancet 336: 624, 1990
  • Carter AO, Gelmon SB, Wells GA, Toepell AP. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidem Inf 103: 539–45, 1989
  • Foulon W, Naessens A, Volckaert M, Lauwers S, Amy JJ. Congenital toxoplasmosis: A prospective survey in Brussels. Br J Obstet Gynaecol 91: 419–23, 1984
  • Foulon W, Naessens A, Lauwers S, Meuter de F, Amy J. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynaecol 72: 419–23, 1980
  • Walls KW. Toxoplasmosis. In: Balows A.O., eds. Laboratory Diagnosis of Infectious Disease. Principles and Practice Vol I. New York. Springer Verlag, 1988
  • Druten van H, Knapen van F, Reintjes A. Epidemiologic implications of limited duration seropositivity after toxoplasma infection. Am J Epidemiol 132: 169–80, 1990
  • Desmonts G. Preventing congenital toxoplasmosis. Lancet 336: 1017–8, 1990
  • Janitschke K. Empfehlungen zur Vorgehensweise bei der Untersuchung auf Toxoplasma-Antikörper in der Schwangeren- und Kinder-Vorsorge. Lab Med 15: 447–9, 1991
  • Ades AE. Evaluating the sensitivity and predictive value of tests of recent infection: Toxoplasmosis in pregnancy. Epidemiol Infect 107: 527–35, 1991
  • Fast CM, Rosegger H, Mayer HO, Aspock H, Schumann. Ausgebrannte intrauterine Toxoplasmose trotz Screening. Pädiatr Pädol 19: 93–7, 1984
  • Wilson CE, Remington JS. What can be done to prevent congenital toxoplasmosis. Am J Obstet Gynaecol 138: 357–63, 1980
  • Gezondheidsraad. Advies inzake de opsporing van aangeboran toxoplasmose. Staatsuitgeverij 's-Gravenhage 1984
  • Ho-Yen DO. Maternal and fetal screening. Br Med J 300: 1527, 1990
  • Marteau TM. Psychological costs of screening. Br Med J 299: 655–60, 1989
  • Jeannel D, Costagliola D, Niel G, Hubert B, Danis M. What is known about the prevention of congenital toxoplasmosis. Lancet 336: 359–61, 1990
  • Remington JS, Desmonts G. Toxoplasmosis. In: Remington & Klein, eds. Infectious diseases of the fetus and newborn infant. 3rd. edition Philadelphia: Saunders Company, 1990
  • Jeannel D, Niel G, Costagliola D, Danis M, Traore EM, Gentilini M. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidmiol 17: 595–602, 1988
  • Jeannel D, Costagliola D, Neil G. The risk of contamination by toxoplasma during pregnancy in the Parisian area. Tenth international meeting on clinical biostatistics, Maastricht, The Netherlands 1989
  • Frenkel JK. Toxoplasma in and around us. Bioscience 23: 343–52, 1973
  • Bull MJV. Screening in practice: Maternal and fetal screening for antenatal care. Br Med J 300: 1118–20, 1990
  • Marteau TM. Screening in practice: Reducing the psychological costs. Br Med J 301: 26–8, 1990
  • Ho-Yen DO, Chatterton JMW Joss AWL. Screening for infections in pregnancy. Lancet i: 1031, 1988
  • Joss AWL, Chatterton JMW, Ho-Yen DO. Congenital toxoplasmosis: To screen or not to screen. Public Health 104: 9–20, 1990
  • McCarthy M. Of cats and women. Br Med J 287: 445–6, 1983
  • Anonymous. Antenatal screening for toxoplasmosis in the UK. Lancet 336: 346–8, 1990
  • Thorp JM, Seeds JW, Herbert WNP, Bowes WA, Maslow AS, Cefalo RC, Chescheir N, Katz VL. Prenatal management and congenital toxoplasmosis. N Engl J med 319: 372–3, 1988
  • Jeannel D, Costagliola D, Niel G, Hubert B, Danis M. What is known about the prevention of congenital toxoplasmosis. Lancet 336: 359–61, 1990
  • Ho-Yen DO, Joss AWL, Chatterton JMW. Letter to the editor. Lancet 336: 624, 1990
  • Jenkins DR. Letter to the editor. Lancet 336: 624, 1990
  • Henderson JB, Beattie CP, Hale EG, Wright T. The evaluation of new services: Possibilities for preventing congenital toxoplasmosis. Int J Epidemiol 13: 65–72, 1984
  • Stray-Pedersen B. Cost-benefit analysis of different pårograms to prevent congenital torch-infections. Albertini A, Crosignani PG, eds. Proceedings of the International Symposium on Progress in Perinatal Medicine. Excerpta Medica, Amsterdam-Oxford-Princeton: 229–37, 1983
  • Frenkel JK. Diagnosis, incidence and prevention of congenital toxoplasmosis. Am J Dis Child 144: 956–7, 1990
  • Conyn-van Spaendonck MAE. Prevention of congenital toxoplasmosis in The Netherlands. Thesis. Rotterdam, 1991
  • Wilson JPM, Jungner G. Principles and practice of screening for disease. Public Health Papers no. 39. World Health Organization; Geneva 1968

References

  • McCabe R Remington JA. Toxoplasmosis: The time has come. N Engl J Med 318: 313–315, 1988
  • Remington JA, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia; WB Saunders, 89–195, 1990
  • Koppe JG, Loewer-Sieger DH, Roevar-Bonnet H. Results of 20 year follow-up of congenital toxoplasmosis. Lancet i: 254–255, 1986
  • Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxoplasmosis infection. Pediatrics 66: 767–774, 1980
  • Hoff R, Weiblen BJ, Reardon LA, Maguire JH. Screening for Congenital Toxoplasma Infection. In: Bellisario R and Mizejewski GJ, eds. Transplacental Disorders: Perinatal Detection, Treatment, and Management, New York, NY: Alan R. Liss, Inc., 169–182, 1990
  • Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal Management of 746 Pregnancies at Risk for Congenital Toxoplasmosis. N Engl J Med, 318: 271–5, 1988
  • Weiblen BJ, GF Grady, Hoff R. Toxoplasmosis Screening. (In review)
  • Naot Y, Desmonts G, Remington JA. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital toxoplasma infection. Pediatrics 98: 32–36, 1981

References

  • Beattie CP. Clinical and Epidemiological Aspects of Toxoplasmosis. Trans R Soc Trop Med 51: 96–103, 1957
  • Fleck DG. Toxoplasmosis and Tristan da Cunha. J Hyg Camb 63: 389–393, 1965
  • Fleck DG. Toxoplasmosis. Public Health 83: 131–135, 1969
  • Williams H. Toxoplasmosis in the perinatal period. Post Grad Med J 53: 614–617, 1977
  • Alexander M, Putzmann L. Untersuchungen über den Durchseuchungsgrad an Toxoplasmose bei der Bevölkerung von Berlin West. Munch Med Wochenschr 11: 1481–1484, 1974
  • Broadbent EJ, Ross R, Hurley R. Screening for Toxoplasmosis in pregnancy. J Clin Pathol 34: 659–664, 1981
  • Flamm H, Aspöck H. Die Toxoplasmose - Überwachung der Schwangerschaft in Östereich -Ergebnisse und Probleme. Paediatr. Grenzeb 20: 27–34, 1981
  • Foulon W, Naessens A, Volckaert ML. Congenital Toxoplasmosis: A prospective study in Brussels. Br J Obstet Gynaecol 91: 419–423, 1984
  • Desmonts G, Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N.Y. Acad Med 50; 146–159, 1974
  • Ruoss CF, Bourne GL. Toxoplasmosis in Pregnancy. J Obstet Gynaecol Br Commonw 79: 1115–1118, 1972
  • Williams KAB, Scott JM, MacFarlane DE, Williamson JMW, Elias Jones TF, Williams H. Congenital toxoplasmosis a prospective survey in the West of Scotland. J Infect 3: 219–229, 1981
  • Joss AWL, Skinner LJ, Chattertion JMW, Chisholm SM, Williams MD, Ho-Yen DO. Simultaneous serological screening for congenital cytomegalovirus and toxoplasma infection. Public Health 102: 409–417, 1988
  • Desmonts G, Couvreur J, Toxoplasmosis: Epidemiological and serological aspects of perinatal infection In: Krugmans Gershon AA, eds, Infections of the Fetus and NewBorn Infant. Progress in Clinical and Biological Research Vol 3 New York. Alan R Liss: 115–132, 1975
  • Joynson DHM, Payne R. Screening for Toxoplasma in Pregnancy. Lancet ii: 795–796, 1988
  • Hall SM, Congenital toxoplasmosis in England Wales and Northern Ireland: Some epidemiological problems. Br Med J 287: 453–455, 1983
  • Hall SM, Glickman M. Report from the British Paediatric Surveillance Unit. Arch Dis Child 65: 807–809, 1990
  • Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 57: 1–17, 1973
  • Bannister B. Toxoplasmosis 1976–80: A review of laboratory reports to the Communicable Disease Surveillance Centre. J Infect: 301–306, 1982
  • Henderson JB, Beattie CP, Hale RG, Wright T. The evaluation of new services: Possibilities for preventing congenital toxoplasmosis. Int J Epidemiol 13: 65–72, 1984
  • Joss AWL, Chatterton JMW, Ho-Yen DO. Congenital Toxoplasmosis; to screen or not to screen? Public Health 104: 9–20, 1990

References

  • Hurley R. Infections in pregnancy. In: Turnbull A, Chamberlain G, eds. Obstetrics. 1st ed. Edinburgh: Churchill Livingstone: 623–40, 1989
  • Antenatal screening for toxoplasmosis in the UK. Editorial, Lancet 336: 346–8, 1990
  • Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of congenital disease. In: Thalhammer O, Baumgarten K, Pollak A eds. Pathophysiology of congenital disease. Perinatal Medicine, 6th European Congress of Vienna, 1978. Stuttgart, West Germany: Georg Thieme Verlag: 51–60, 1979
  • Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66: 767–74, 1980
  • Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 3nd ed. Philadelphia: W. B. Saunders: 98–195, 1990
  • James K. Immunoserology in infectious diseases. Clin Microbiol Rev 3: 132–52, 1990
  • Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D . Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318: 271–5, 1988
  • Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1: 500–4, 1985
  • Koskiniemi M, Lappalainen M, Hedman K. Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child 143: 724–8, 1989
  • Fuith LC, Reibnegger G, Hönlinger M, Wachter H. Screening for toxoplasmosis in pregnancy. Lancet 2; 1196, 1988
  • Desmonts G. Preventing congenital toxoplasmosis. Lancet 336: 1017–8, 1990
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–5, 1970
  • Bers G, Garfin D. Protein and nucleic acid blotting and immunobiochemical detection. BioTechniques 3: 276–88, 1985
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76: 4350–4, 1979
  • Hedman K, Lappalainen M, Seppälä I, Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J infect Dis 159: 736–40, 1989
  • Hedman K, Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin immunol 8: 214–21, 1988
  • McCabe R, Remington JS. The diagnosis and treatment of toxoplasmosis. Eur J Clin Microbiol 2: 95–104, 1983
  • Brooks RG, McCabe RE, Remington JS. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis 9: 1055–62, 1987
  • Kimball AC, Kean BH, Fritz Fuchs MD, Congenital toxoplasmosis: A prospective study of 4048 obstetric patients. Am J Obstet Gynecol 3: 211–7, 1971
  • Frenkel JK, Ruiz A. Human toxoplasmosis and cat contacts in Costa Rica. Am J Trop Med Hyg 29: 1167–80, 1980
  • Ahlfors K, Börjeson M, Huldt G, Forsberg E. Incidence of toxoplasmosis in pregnant women in the city of Malmö, Sweden. Scand J Infect Dis 21: 315–21, 1989
  • Stray-Pedersen B, Lorentzen-Styr AM. The prevalence of toxoplasma antibodies among 11,736 pregnant women in Norway. Scand J Infect Dis 11: 159–65, 1979
  • Lappalainen M, Koskela P, Hedman K, Teramo K, Ämmälä P, Hiilesmaa V, Koskiniemi M. Incidence of primary toxoplasma infections during pregnancy in Southern Finland: A prospective cohort study. Scand J Infect Dis 24: 97–104, 1992
  • Rajantie J, Taskinen E, Lappalainen M, Siimes M, Koskiniemi M. White blood cells in infants with congenital toxoplasmosis: Transient appearame of call antigen on reactive narrow lymphocytes. Scand J Infect Dis 24: 22–232, 1992

References

  • World Health Organization. Report of the WHO consultation on public health aspects of toxoplasmosis. Hanover October 1987. WHO/CDS/VPH/88.74: 2–14, 1988
  • Desmonts G. Preventing congenital toxoplasmosis. Lancet 236: 1017–18, 1990
  • Aspöck H. Uberwachung von toxoplasmose während der schwangerschaft. Obergurgl febr. 1982. Gynaek Rdsch 23: 57–65, 1983
  • Conyn-Van Spaendonck MAE. Prevention of congenital toxoplasmosis in the netherlands. Thesis. Tilburg: Van Spaendonck Drukkerij B.V., 1991
  • Prenatal screening for toxoplasmosis in the UK. Report of a multidisciplinary working group. London: The Royal College of Obstetricians and Gynaecologists, 1–14, 1992
  • Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of the outcome of pregnancy in 542 woman with toxoplasmosis acquired during pregnancy. Ann Pediat 31: 805–809, 1984
  • Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders, 90–195, 1990
  • Hedman K, Lappalainen M, Seppala I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG avidity. J Infect Dis 159: 736740, 1989
  • Couvreur J, Desmonts G, Aron-Rosa D. Ocular prognosis in congenital toxoplasmosis. Role of management. Preliminary communication. Ann Pediat 31: 855–858, 1984
  • Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66: 767–774, 1980
  • Piens MA, Garin JP. New perspectives in the chemoprophylaxis of toxoplasmosis. J Chemotherapy 1: 46–51, 1989

References

  • Stray-Pedersen B, Pedersen JO, Omland T. Estimations of the incidence of toxoplasma infections among pregnant women from different areas in Norway. Scand J Infect Dis 11: 247–252, 1979
  • Stray-Pedersen B. Toxoplasma infection and pregnancy. Thesis, Oslo University. AS Bryne, 1–109, 1978
  • Stray-Pedersen B, Lorentzen-Styr A-M. The prevalence of Toxoplasma antibodies among 11736 pregnant women in Norway. Scand J Infect Dis 11: 159–165, 1979
  • Stray-Pedersen B. A prospective study of acquired toxoplasmosis among 8043 pregnant women in the Oslo area. Am J Obstet Gynecol 136: 399–403, 1980
  • Stray-Pedersen B. Infants potentially at risk for congenital toxoplasmosis. Am J Dis Child 134: 638–642, 1980
  • Stray-Pedersen B, Lorentzen-Styr AM. Epidemiological aspects of Toxoplasma infections among women in Norway. Acta Obstet Gynecol 59: 323–326, 1981
  • Hauger T, Stray-Pedersen B. Cost-benefit analysis for prevention of congenital toxoplasmosis. National Institute of Public Health, Oslo, 1976
  • Wilson CB, Remington JS, Stagno S . Development of adverse sequelae in children born with subclinical Toxoplasma infection. Pediatrics 66: 767–774, 1980
  • Koppe JG, Loewer-Sieger DM, Roever-Bonnet H. Results of 20-years follow up of congenital toxoplasmosis. Lancet, Feb 1, 254–56, 1986
  • Couvreur J, Desmonts G, Thulliez Ph. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrobial Chemother 22: Suppl B, 193–200, 1988
  • Hohlfeld J, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F. Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115:765–9, 1989
  • Couvreur J, Desmonts G, Aron-Rosa D. Ocular prognosis on congenital toxoplasmosis. Role of management. Preliminary communication. Ann Pediat 31: 855–858, 1984
  • World Health Organization. Report of the WHO consultation on Public Health Aspects of Toxoplasmosis. WHO/CDS/VPH 74: 214, 1988

References

  • Remington JS, Desmonts J. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and the Newborn Infant. 3rd. ed. Philadelphia, WB Saunders Company, pp. 90–195, 1990
  • Koppe JG, Loewer-Sieger DM, Roever-Bonnet H. Results of 20-years follow up of congenital toxoplasmosis. Lancet, Feb 1, 254–56, 1986
  • Wilson CB, Remington JS, Stagno S Development of adverse sequelae in children born with subclinical Toxoplasma infection. Pediatrics 66: 767–774, 1980
  • Couvreur J, Desmonts C. Behandlung der erworben Toxoplasmose wahrend der schwangerschaft mit spiramycin. Zbl Gynakol 105: 1104–1107, 1983
  • Couvreur J, Desmonts G, Thulliez Ph. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrobial Chemother 22: Suppl B, 193–200, 1988
  • McGee T, Wolters C, Stein L. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngology 106: 75–80, 1992
  • Stray-Pedersen B. A prospective study of acquired toxoplasmosis among 8043 pregnant women in the Oslo area. Am J Obstet Gynecol 136: 399–403, 1980
  • Henderson JB, Beattie CP, Hale EG. The evaluation of new services: Possibilities for preventing congenital toxoplasmosis. Int J Epid 13: 6572, 1984
  • Roberts T, Frenkel JK. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. JAVMA 196: 2, 249–256, 1990
  • Wilson CB, Remington JS. What can be done to prevent congenital toxoplasmosis Am J Obstet Gynecol 138: 357–363, 1980
  • Stray-Pedersen B, Lorentzen-Styr AM. Epidemiological aspects of Toxoplasma infections among women in Norway. Acta Obstet Gynecol 59: 323–326, 1981
  • WHO publication. WHO Model Prescribing Information - Drugs used in Parasitic Diseases. pp. 53–60, 1990
  • Stray-Pedersen B. Cost-benefit analysis of different programmes to prevent congenital TORCH infection In: Albertini (ed.) Progress in Perinatal Medicine, Amsterdam-Oxford Excerpta Medica, pp. 229–37, 1983
  • Foulon W, Naessens A, Lauwers S (1988). Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obst Gynecol 72: S3, 363–366, 1988
  • Foulon W. Prevention of congenital toxoplasmosis. PhD thesis, University of Vrije, Brussels, 1992
  • Forsgren M, Gille E, Ljungstrom I. Toxoplasma antibodies in pregnant women in Stockholm in 1969, 1979 and 1987 Lancet 337: 1431–14, 1991
  • Desmonts G, Couvreur J. Congenital toxoplasmosis A prospective study of 378 pregnancies. New Eng J Med 290: 1110–1116, 1974
  • WHO publication. Report of the WHO consultation on Public Health Aspects of Toxoplasmosis. WHO/CDS/VPH 74: 2–14, 1988
  • Stutzner D, Mayer HO, Mose JR. Screening for toxoplasmosis in pregnancy and surveillance of children born to mothers with acute infection during pregnancy. Int J Feto. Maternal Med. 1991
  • Joss AWL, Skinner LJ, Chatterton JMW. Simultaneous serological screening for congenital cytomegalovirus and toxoplasma infection. Public Health 102: 409–417, 1988

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.